Oaktree Acquisition III Life Sciences Debt to Equity Ratio 2025-2024 | OACC
Current and historical debt to equity ratio values for Oaktree Acquisition III Life Sciences (OACC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Oaktree Acquisition III Life Sciences debt/equity for the three months ending September 30, 2024 was 0.00.
| Oaktree Acquisition III Life Sciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-09-30 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.224B |
$0.000B |
|
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
|
